Navigation Links
Japanese Fund Moves Quickly to Invest in Promising Technology Against Malaria, Tuberculosis And Chagas Disease
Date:11/7/2013

are the current gold-standard anti-malarial treatments that combine fast-acting artemisinin derivatives with a long-acting partner drug. The new drug candidate, DSM265, which kills the malaria parasite through inhibition of an essential enzyme, is a compound with a long duration of action that could potentially be part of a new treatment for malaria, with potential for being part of a single dose cure. The compound recently entered clinical phase I studies in healthy human volunteers. If the planned studies show that it works safely and effectively, DSM265 could undergo later-stage development as a new option in the treatment of malaria.

An additional award of approximately US$575,000 was granted to MMV in partnership with Takeda for development and its formulation of ELQ300, an anti-malarial compound that is in earlier stages of development. ELQ300 has the potential to be given once a month to treat and prevent malarial infections, which would make it an important tool in the control of malaria. However, some additional work related to its formulation is needed before it can be tested in patients.

The GHIT Fund will also invest in candidate products for tuberculosis and Chagas disease. For tuberculosis, a disease that causes an estimated 8.6 million new cases and kills about 1.3 million people annually, the Fund will invest US$720,000 for early work on a novel vaccine candidate against tuberculosis being co-developed by the National Institute of Biomedical Innovation, Japan's Create Vaccine Co., Ltd. and Aeras, an international non-profit biotech based in Washington, DC. The vaccine is the first to target the patient's mucous membranes to keep TB from making an entry into the lungs. In mice, the vaccine added protection to BCG, the current vaccine against tuberculosis. BCG was invented nearly 90 years ago and provides insufficient protection to teenagers and adults, the group with the highest TB bu
'/>"/>

SOURCE Global Health Innovative Technology Fund (GHIT Fund)
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Japanese Market for Orthopedic Soft Tissue Repair & Sports Medicine
2. The Japanese Cancer Association and Debiopharm Group Present Doctors Oshima and Tanaka with the 2012 JCA-Mauvernay Award for their Innovative and Outstanding Cancer Research
3. Immunomic Therapeutics Begins Phase I Japanese Red Cedar JRC-LAMP-Vax Vaccine Safety Study
4. Neuland Labs Strengthens Commitment to Japanese Market With New Manufacturing Collaboration With Mitsubishi Healthcare Unit API Corporation
5. Reimbursement Cuts Will Challenge Japanese Interventional Cardiology Device Market
6. Oramed Pharmaceuticals Granted Japanese Patent for its Core Technology in Oral Delivery of Proteins
7. Immunomic Therapeutics Announces Interim Data Analysis of Phase I Study to Treat Japanese Red Cedar Allergy
8. Japanese Heart Valve Device Market Growth Will Spike With The Launch of Transcatheter Heart Valves
9. The Japanese Market For Peripheral Vascular Devices Will Be Characterized By New Product Launches In Many Segments
10. The Japanese Embolization Particle Market Will Witness Significant Market Activity And Rapid Growth Due To New Product Approvals
11. SMT C1100 For Duchenne Muscular Dystrophy Moves To Human Testing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... , Aug. 22, 2014  Cannabis Science, Inc. ... formulation-based drug development and related consulting, is pleased ... international medical cannabis conference taking place at the ... , on October 22, 2014.  The multilingual ... such as researchers, health professionals, and patients, to ...
(Date:8/21/2014)...  Aptuit LLC announces that Aptuit SSCI, located ... has enhanced its capabilities in the areas of ... molecules, including biologic drugs, metabolites, and polymers, through ... spectrometer. In making the announcement, Dr. ... expanded large molecule capability enhances our early development ...
(Date:8/21/2014)...  eRelevance Corporation ( www.erelevancecorp.com ), a progressive ... has completed integration with Nextech, a popular Electronic ... Dermatology practices. "Integration allows our service ... using Nextech," stated Bob Fabbio , co-founder ... the EMR we are able to automatically target ...
Breaking Medicine Technology:Cannabis Science, Inc. (CBIS) to Sponsor 3rd International Conference on Cannabinoids in Medicine in October 2014 in Strasbourg, France 2Cannabis Science, Inc. (CBIS) to Sponsor 3rd International Conference on Cannabinoids in Medicine in October 2014 in Strasbourg, France 3Aptuit SSCI Adds Ultra High Resolution Q-TOF Mass Spectrometer for Large & Small Molecule Analyses 2eRelevance Corporation Integrates with Nextech Electronic Medical Records 2
... BEIJING, Nov. 11, 2010 /PRNewswire-Asia-FirstCall/ -- Dehaier Medical Systems ... "Company"), an emerging leader in the development, assembly, marketing ... in China, today announced that it will hold a ... quarter and nine months ended September 30, 2010. The ...
... KNDL ), a leading, global full-service clinical research ... Lazard Capital Markets 7th Annual Healthcare Conference on Nov. 16, ... City. Kendle,s formal presentation will be given at ... President and Chief Operating Officer and Keith Cheesman, Senior Vice ...
Cached Medicine Technology:Dehaier Medical Announces Conference Call to Discuss Third Quarter 2010 Financial Results 2Kendle to Present at Lazard Capital Markets 7th Annual Healthcare Conference 2
(Date:8/22/2014)... 2014 Eagerly embracing intended parents around ... and now offers the top male infertility programs — ... The fertility network of IVFinMexico.com continues to ... reproductive care, female and male infertility, advanced research and ... standards so eminently set by company CEO and Founder ...
(Date:8/22/2014)... FRIDAY, Aug. 22, 2014 (HealthDay News) -- An intensive effort ... to an animal shelter in Florida and euthanized, a new ... enough cats to slow their intake into animal control," Dr. ... of Florida College of Veterinary Medicine, said in a university ... there wasn,t making a big impact," she explained, "so we ...
(Date:8/22/2014)... August 22, 2014 A national leader in ... new offices with room to grow. , Headquarters for the ... a 60,000-square-foot office building at 8516 N.W. Expressway in Oklahoma ... one of the Oklahoma’s best places to work by OKCBiz ... company has hired 120 in the past two years, and ...
(Date:8/22/2014)... 2014 Home Care Assistance of ... for seniors, is proud to announce the next installment ... webinar will feature Dr. Suzanne Steinbaum, attending cardiologist and ... in New York City, National Spokesperson for the American ... will cover the issues surrounding women and heart disease, ...
(Date:8/22/2014)... -- Inner city children have a higher-than-normal risk of developing ... inner city children in four U.S. cities -- Baltimore, Boston, ... 5 and found that at least 10 percent of them ... only the three most common types of food allergies were ... youngsters with food allergies may be even higher, the researchers ...
Breaking Medicine News(10 mins):Health News:Mexico Now Offers Top Program for Couples Suffering from Male Infertility 2Health News:Mexico Now Offers Top Program for Couples Suffering from Male Infertility 3Health News:Mexico Now Offers Top Program for Couples Suffering from Male Infertility 4Health News:Neutering Project Curbed Feral Cat Population 2Health News:Fast-growing 180 Medical Moves Into New 60,000-square-foot Office in Oklahoma City 2Health News:Home Care Assistance of Centennial to Host Webinar on Heart Health, Featuring Dr. Suzanne Steinbaum 2Health News:Home Care Assistance of Centennial to Host Webinar on Heart Health, Featuring Dr. Suzanne Steinbaum 3Health News:Food Allergies More Common Among Inner City Kids, Study Finds 2
... common blood thinners also are taken , , FRIDAY, March 13 ... appears to be safe and tolerable in preventing blood ... at the Duke Clinical Research Institute. , The trial included ... undergo either percutaneous coronary intervention (PCI) -- a procedure to ...
... Cherubs(R) Spokeskid in the ,Be the Next Sweet Sensation, ... about NatureSweet(R) Cherubs(R) bite-sized tomatoes as the sweetest snacking ... for kids entitled "Be the Next Sweet Sensation". The ... program including online, retail, print, PR and radio support. ...
... a continued effort to provide perioperative solutions that ... and safer care, Surgical Information Systems (SIS) now ... Solution to Pyxis Supply Technologies; a division of ... of economic uncertainty, it is now more important ...
... Unnecessarily Every Year From Preventable Medical Errors , ... ... National Patient Safety Awareness Week , Quantros , a ... industry, has produced an educational video that exposes the staggering numbers ...
... Refugee Health and Human Rights (BCRHHR) at Boston ... number of Tibetan refugee monks who fled violent ... from symptoms of traumatic stress, interfering with their ... traditional healers as having srog-rLung, a life-wind imbalance. ...
... The National Association of Boards of Pharmacy(R) (NABP(R)) is ... Award of Excellence in the first round of the ... competition sponsored by the American Society of Association Executives ... based in Mount Prospect, IL, received the award for ...
Cached Medicine News:Health News:Investigational Drug May Help Avert Blood Clots 2Health News:NatureSweet(R) Celebrates Snacking With an Online Natural Talent Show 2Health News:SIS Offers Increased Financial and Operational Efficiencies with Pyxis Supply Technologies 2Health News:Quantros Produces Video Detailing Enormous Problem of Preventable Medical Errors Plaguing The U.S. Healthcare System 2Health News:Quantros Produces Video Detailing Enormous Problem of Preventable Medical Errors Plaguing The U.S. Healthcare System 3Health News:Researchers discover ways of integrating treatment of traumatized Tibetan refugee monks 2Health News:Researchers discover ways of integrating treatment of traumatized Tibetan refugee monks 3Health News:NABP Wins ASAE's 2009 Associations Advance America Award of Excellence 2Health News:NABP Wins ASAE's 2009 Associations Advance America Award of Excellence 3
Bougie Urethrotomes for slitting the female urethra and for meatus stenosis in males...
OES Pro Optical Urethrotome...
ACMI urethrotomes are available in two distinct styles to meet your specific professional needs. The Classic Series™ Otis Urethrotome consists of a blade, straight tip, and ball tip, with an av...
... line combines market-leading optical ... durable hardware. The color-coded ... robust, ergonomic design and ... on Stryker endoscopes. The ...
Medicine Products: